Citryll’s shareholders are the founders, ModiQuest, Dutch venture capitalists BOM and Curie Capital, Brightgene , a biotech in China funded by, among others Sequoia China and Highlight Capital and represented by Laurel Venture, and recent investors Biogeneration Ventures and Seventure.